SPRY1

Chr 4

sprouty RTK signaling antagonist 1

Also known as: hSPRY1

Predicted to enable protein kinase inhibitor activity. Involved in negative regulation of fibroblast growth factor receptor signaling pathway. Predicted to be located in plasma membrane. Predicted to be active in cytosol. [provided by Alliance of Genome Resources, Jun 2026]

OMIMResearchGenerating clinical summary…
0
Active trials
—
Pubs (1 yr)
—
P/LP submissions
—
P/LP missense
1.22
LOEUF
Multiple*
Mechanism· predicted

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.22LOEUF
pLI 0.003
Z-score 1.14
OE 0.58 (0.30–1.22)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
-0.95Z-score
OE missense 1.21 (1.08–1.36)
200 obs / 165.6 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.58 (0.30–1.22)
0≤0.351.4
Missense OE?1.21 (1.08–1.36)
0≤0.61.4
Synonymous OE?1.11
0≤1.21.6
LoF obs/exp: 5 / 8.6Missense obs/exp: 200 / 165.6Syn Z: -0.72

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

SPRY1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →